PharmaCCX Company

PharmaCCX is an independent, third-party technology platform created for the industry, by the industry. We are 100% focused on helping pharma and payers improve patient outcomes by more efficiently reaching access agreements in areas such as combination therapies, indication-based pricing, gene therapy and value-based deals. By using our platform, pharma companies make “contingent commitments” until they are able to agree on pricing with payers. We do not take sides — instead, we work collaboratively with all parties involved in a negotiation to help increase patient access to promising, life-saving therapies.

Total Funding: 3000000
Headquarters: Boston, Massachusetts, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Series A
Technology: Neurological Disorders
Founded Date: 2017-12-01
Industry: Pharmtech